Rapport Therapeutics, Inc. — Director's Dealing 2025

Jun 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Rapport Therapeutics, Inc. (RAPP)
CIK: 0002012593
Period of Report: 2025-06-17

Reporting Person: Sanchez Ramiro (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-17	Stock Option (Right to Buy)	$10.95	A	10925	Acquired	2035-06-17	Common Stock (10925)	Direct

Footnotes

F1: The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.